Market closed
Biofrontera Inc./$BFRI
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Biofrontera Inc.
Biofrontera Inc is a United States-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy. The Company's licensed products, which include Ameluz as well as the BF-RhodoLED and RhodoLED XL lamps (together, the RhodoLED Lamps), are used for the treatment of actinic keratoses (AKs), which are pre-cancerous skin lesions.
Ticker
$BFRI
Sector
Trading on
Industry
Pharmaceuticals
Headquarters
Employees
93
Website
Biofrontera Inc. Metrics
BasicAdvanced
$7.1M
-
-$3.22
0.37
-
Price and volume
Market cap
$7.1M
Beta
0.37
52-week high
$1.10
52-week low
$0.65
Average daily volume
91K
Financial strength
Current ratio
1.722
Quick ratio
0.934
Long term debt to equity
98.669
Total debt to equity
111.031
Interest coverage (TTM)
-8.17%
Management effectiveness
Return on assets (TTM)
-43.00%
Return on equity (TTM)
-384.98%
Valuation
Price to revenue (TTM)
0.118
Price to book
1.6
Price to tangible book (TTM)
1.62
Price to free cash flow (TTM)
-0.428
Growth
Revenue change (TTM)
9.54%
Earnings per share change (TTM)
-75.27%
3-year revenue growth (CAGR)
15.69%
3-year earnings per share growth (CAGR)
-66.50%
Biofrontera Inc. News
AllArticlesVideos
Biofrontera Inc. (BFRI) Q4 2024 Earnings Call Transcript
Seeking Alpha·4 weeks ago
Biofrontera Inc. Reports Record Fiscal Year 2024 Financial Results and Provides a Business Update
GlobeNewsWire·4 weeks ago
Biofrontera Inc. Announces Completion of Patient Enrollment in Phase 3 Study of Ameluz® (aminolevulinic acid HCI) Topical Gel, 10% for the Treatment of Actinic Keratoses on the Extremities, Neck and Trunk
GlobeNewsWire·4 weeks ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Biofrontera Inc. stock?
Biofrontera Inc. (BFRI) has a market cap of $7.1M as of April 16, 2025.
What is the P/E ratio for Biofrontera Inc. stock?
The price to earnings (P/E) ratio for Biofrontera Inc. (BFRI) stock is 0 as of April 16, 2025.
Does Biofrontera Inc. stock pay dividends?
No, Biofrontera Inc. (BFRI) stock does not pay dividends to its shareholders as of April 16, 2025.
When is the next Biofrontera Inc. dividend payment date?
Biofrontera Inc. (BFRI) stock does not pay dividends to its shareholders.
What is the beta indicator for Biofrontera Inc.?
Biofrontera Inc. (BFRI) has a beta rating of 0.37. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.